| Title |
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2022
|
| DOI | 10.1002/14651858.cd013444.pub2 |
| Pubmed ID | |
| Authors |
Graziella Filippini, Silvia Minozzi, Francesca Borrelli, Michela Cinquini, Kerry Dwan |
X Demographics
The data shown below were collected from the profiles of 73 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 14 | 19% |
| United Kingdom | 4 | 5% |
| United States | 4 | 5% |
| Japan | 3 | 4% |
| Colombia | 3 | 4% |
| Germany | 3 | 4% |
| Brazil | 2 | 3% |
| Chile | 2 | 3% |
| Mexico | 2 | 3% |
| Other | 9 | 12% |
| Unknown | 27 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 61 | 84% |
| Practitioners (doctors, other healthcare professionals) | 8 | 11% |
| Scientists | 3 | 4% |
| Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 150 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 9% |
| Student > Master | 13 | 9% |
| Student > Ph. D. Student | 12 | 8% |
| Other | 11 | 7% |
| Student > Bachelor | 8 | 5% |
| Other | 23 | 15% |
| Unknown | 69 | 46% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 25 | 17% |
| Biochemistry, Genetics and Molecular Biology | 8 | 5% |
| Neuroscience | 8 | 5% |
| Nursing and Health Professions | 7 | 5% |
| Unspecified | 5 | 3% |
| Other | 21 | 14% |
| Unknown | 76 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 70. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2023.
All research outputs
#591,055
of 24,891,087 outputs
Outputs from Cochrane database of systematic reviews
#1,091
of 13,000 outputs
Outputs of similar age
#15,148
of 434,853 outputs
Outputs of similar age from Cochrane database of systematic reviews
#13
of 122 outputs
Altmetric has tracked 24,891,087 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,000 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.1. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,853 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 122 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.